Different affinity of galectins for human serum glycoproteins: Galectin-3 binds many protease inhibitors and acute phase proteins

Glycobiology

Volumn 18, Issue 5, 2008, Pages 384-394

  Cederfur, Cecilia ^a   Salomonsson, Emma ^a   Nilsson, Jonas ^b   Halim, Adnan ^b   Öberg, Christopher T ^a   Larson, Göran ^b   Nilsson, Ulf J ^a   Leffler, Hakon ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 2 MACROGLOBULIN; ECALECTIN; GALECTIN 2; GALECTIN 3; GALECTIN 8; GLYCOPROTEIN; HAPTOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; N ACETYLLACTOSAMINE SYNTHASE; PROTEINASE INHIBITOR; TRANSFERRIN;

AFFINITY CHROMATOGRAPHY; ANISOTROPY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ELECTROPHORESIS; ENDOTHELIUM CELL; FLUORESCENCE ANALYSIS; HUMAN; MASS SPECTROMETRY; MOLECULAR MODEL; MUTANT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WESTERN BLOTTING;

ACUTE-PHASE PROTEINS; BINDING SITES; CHROMATOGRAPHY, AFFINITY; FLUORESCENCE POLARIZATION; GALECTIN 3; GALECTINS; GLYCOPROTEINS; HUMANS; KINETICS; LIGANDS; PROTEASE INHIBITORS;

EID: 42449153703     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwn015     Document Type: Article

References (55)

1. Almkvist J and Karlsson A. 2004. Galectins as inflammatory mediators. Glycoconj J. 19:575-581.
2. Arnold JN, Wallis R, Willis AC, Harvey DJ, Royle L, Dwek RA, Rudd PM, Sim RB. 2006. Interaction of mannan binding lectin with alpha2 macroglobulin via exposed oligomannose glycans: A conserved feature of the thiol ester protein family? J Biol Chem. 281:6955-6963.
3. Baptiste TA, James A, Saria M, Ochieng J. 2007. Mechano-transduction mediated secretion and uptake of galectin-3 in breast carcinoma cells: Implications in the extracellular functions of the lectin. Exp Cell Res. 313:652-664.
4. Bonacci GR, Caceres LC, Sanchez MC, Chiabrando GA. 2007. Activated alpha(2)-macroglobulin induces cell proliferation and mitogen-activated protein kinase activation by LRP-1 in the J774 macrophage-derived cell line. Arch Biochem Biophys. 460:100-106.
5. Bresalier RS, Byrd JC, Tessler D, Lebel J, Koomen J, Hawke D, Half E, Liu KF, Mazurek N. 2004. A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer. Gastroenterology. 127:741-748.
6. Brewer CF. 2002. Binding and cross-linking properties of galectins. Biochim Biophys Acta. 1572:255-262.
7. Cabrera PV, Amano M, Mitoma J, Chan J, Said J, Fukuda M, Baum LG. 2006. Haploinsufficiency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell death. Blood. 108:2399-2406.
8. Carcamo C, Pardo E, Oyanadel C, Bravo-Zehnder M, Bull P, Caceres M, Martinez J, Massardo L, Jacobelli S, Gonzalez A, et al. 2006. Galectin-8 binds specific beta1 integrins and induces polarized spreading highlighted by asymmetric lamellipodia in Jurkat T cells. Exp Cell Res. 312:374-386.
9. Carlsson S, Oberg CT, Carlsson MC, Sundin A, Nilsson UJ, Smith D, Cummings RD, Almkvist J, Karlsson A, Leffler H. 2007. Affinity of galectin-8 and its carbohydrate recognition domains for ligands in solution and at the cell surface. Glycobiology. 17:663-676.
10. Cumpstey I, Salomonsson E, Sundin A, Leffler H, Nilsson UJ. 2007. Studies of arginine-arene interactions through synthesis and evaluation of a series of galectin-binding aromatic lactose esters. Chembiochem. 8:1389-1398.
11. Danielsen EM and Hansen GH. 2006. Lipid raft organization and function in brush borders of epithelial cells (Review). Mol Membr Biol. 23:71-79.
12. Delacour D, Greb C, Koch A, Salomonsson E, Leffler H, Le Bivic A, Jacob R. 2007. Apical sorting by galectin-3-dependent glycoprotein clustering. Traffic. 8:379-388.
13. Dumic J, Dabelic S, Flogel M. 2006. Galectin-3: An open-ended story. Biochim Biophys Acta. 1760:616-635.
14. Ferens-Sieczkowska M and Olczak M. 2001. Carbohydrate structures of haptoglobin in sera of healthy people and a patient with congenital disorder of glycosylation. Z Naturforsch [C]. 56:122-131.
15. Finne J, Breimer ME, Hansson GC, Karlsson KA, Leffler H, Vliegenthart JF, van Halbeek H. 1989. Novel polyfucosylated N-linked glycopeptides with blood group A, H, X, and Y determinants from human small intestinal epithelial cells. J Biol Chem. 264:5720-5735.
16. Fry SA, Steen PE, Royle L, Wormald MR, Leathem AJ, Opdenakker G, McDonnell JM, Dwek RA, Rudd PM. 2006. Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3. Biochemistry. 45:15249-15258.
17. Grassadonia A, Tinari N, Iurisci I, Piccolo E, Cumashi A, Innominato P, D'Egidio M, Natoli C, Piantelli M, Iacobelli S. 2004. 90K (Mac-2 BP) and galectins in tumor progression and metastasis. Glycoconj J. 19:551-556.
18. Gunnarsson M, Jenssen PEH. 1998. Binding of soluble myelin basic protein to various conformational forms of alpha-2-macroglobulin. Arch Biochem Biophys. 359:192-198.
19. Hernandez JD, Nguyen JT, He J, Wang W, Ardman, B, Green JM, Fukuda M, Baum LG. 2006. Galectin-1 binds different CD43 glycoforms to cluster CD43 and regulate T cell death. J Immunol. 177:5328-5336.
20. Hirabayashi J, Hashidate T, Arata Y, Nishi N, Nakamura T, Hirashima M, Urashima T, Oka T, Futai M, Muller WE, et al. 2002. Oligosaccharide specificity of galectins: A search by frontal affinity chromatography. Biochim Biophys Acta. 1572:232-254.
21. Hirashima M, Kashio Y, Nishi N, Yamauchi A, Imaizumi TA, Kageshita T, Saita N, Nakamura T. 2004. Galectin-9 in physiological and pathological conditions. Glycoconj J. 19:593-600.
22. Huflejt ME and Leffler H. 2004. Galectin-4 in normal tissues and cancer. Glycoconj J. 20:247-255.
23. Ideo H, Seko A, Yamashita K. 2005. Galectin-4 binds to sulfated glycosphingolipids and carcinoembryonic antigen in patches on the cell surface of human colon adenocarcinoma cells. J Biol Chem. 280:4730-4737.
24. Kits, Y, Miura Y, Furukawa J, Nakano M, Shinohara Y, Ohno M, Takimoto A, Nishimura S. 2007. Quantitative glycomics of human whole serum glycoproteins based on the standardized protocol for liberating N glycans. Mol Cell Proteomics. 6:1437-1445.
25. Krapp S, Mimura Y, Jefferis R, Huber R. Sondermann P. 2003. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol. 325:979-989.
26. Lahm H, Andre S. Hoeflich A, Kaltner H, Sieben HC, Sordat B, von der Lieth CW, Wolf E, Gabius W. 2004. Tumor galectinology: Insights into the complex network of a family of endogenous lectins. Glycoconj J. 20:227-238.
27. Larsen K. Macleod D, Nihlberg K. Gurcan E. Bjermer L. Marko-Varga G. Westergren-Thorsson G. 2006. Specific haptoglobin expression in bronchoalveolar lavage during differentiation of circulating fibroblast progenitor cells in mild asthma. J Proteome Res. 5:1479-1483.
28. Lau KS, Partridge EA, Grigorian A. Silvescu CI, Reinhold VN, Demetriou M, Dennis JW. 2007. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell. 129:123-134.
29. Laurell CB. 1966. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 15:45-52.
30. Leffler H, Carlsson S, Hedlund M, Qian Y, Poirier F. 2004. Introduction to galectins. Glycoconj J. 19:433-440.
31. Leppanen A, Stowell S, Blixt O, Cummings RD. 2005. Dimeric galectin-1 binds with high affinity to alpha2,3-sialylated and non-sialylated terminal N-acetyllactosamine units on surface-bound extended glycans. J Biol Chem. 280:5549-5562.
32. Levander F, Rognvaldsson T, Samuelsson J, James P. 2004. Automated methods for improved protein identification by peptide mass fingerprinting. Proteomics. 4:2594-2601.
33. Mattu TS, Pleass RJ, Willis AC, Kilian M, Wormald MR, Lellouch AC, Rudd PM, Woof JM, Dwek RA. 1998. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc alpha receptor interactions. J Biol Chem. 273:2260-2272.
34. Merkle RK and Cummings RD. 1988. Asparagine-linked oligosaccharides containing poly-N-acetyllactosamine chains are preferentially bound by immobilized calf heart agglutinin. J Biol Chem. 263:16143-16149.
35. Nagae N, Nishi N, Nakamura-Tsuruta S. Hirabayashi J, Wakatsuki SKR 2008. Structural analysis of the human galectin-9N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue. J Mol Biol. 375:119-135.
36. Nieminen J, Kuno A, Hirabayashi J, Sato S. 2007. Visualization of galectin-3 oligomerization on the surface of neutrophils and endothelial cells using fluorescence resonance energy transfer. J Biol Chem. 282:1374-1383.
37. Patnaik SK, Potvin B, Carlsson S, Sturin D, Leffler H, Stanley P. 2006. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells. Glycobiology. 16:305-317.
38. Poirier F. 2002. Roles of galectins in vivo. Biochem Soc Symp. 95-103.
39. Rabinovich GA, Liu FT, Hirashima M, Anderson A. 2007. An emerging role for galectins in tuning the immune response: Lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scand J Immunol. 66: 143-158.
40. Rippe B and Haraldsson B. 1994. Transport of macromolecules across microvascular walls: The two-pore theory. Physiol Rev. 74:163-219.
41. Salameh BA, Sundin A, Leffler H, Nilsson UJ. 2006. Thioureido N acetyllactosamine derivatives as potent galectin-7 and 9N inhibitors. Bioorg Med Chem. 14:12415-1220.
42. Satomi Y, Shimonishi Y, Hase T, Takao T. 2004. Site specific carbohydrate profiling of human transferrin by nano-flow liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom. 18:2983-2988.
43. Saussez S, Lotfevre F, Lequeux T, Laurent G, Chantrain G, Vertongen F; Toubeau G, Decaestecker C, Kiss R. 2008. The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy. Oral Oncol. 44:86-93.
44. Smith AC, de Wolff JF, Molyneux K, Feehally J, Barratt, J. 2006. O-Glycosylation of serum IgD in IgA. nepropathy. J Am Soc Nephrol. 17:1192-1199.
45. Sorme P, Kahl-Knutsson B, Huflejt M, Nilsson, UJ. Leffler H. 2004. Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions Anal Biochem. 334:36-47.
46. Stillman BN, Hsu DK, Pang M. Brewer CF. Johnson P. Liu FT. Baum LG. 2006. Galectin-3 and galectin- 1 bind distinct cell surface glycoproteiri receptors to induce T cell death. J Immunol. 176:778-789.
47. Stowell SR, Arthur CM, Mehta P, Slanina KA, Blixt O, Leffler H, Smith DF, Cummings RD. 2008. Galectins-1, -2 and -3 exhibit differential recognition of sialylated glycans and blood group antigens. J Biol Chem.
48. Thijssen VL, Hulsmans S, Griffioen AW. 2008. The galectin profile of the endothelium: Altered expression and localization in activated and tumor endothelial cells. Am J Pathol. 172:545-553.
49. Thijssen VL, Poirier F, Baum LG, Griffioen AW. 2007. Galectins in the tumor endothelium; oppoftunities for combined calicer therapy. Blood. 110:2819-2827.
50. Toscano MA, Bianco GA, Ilarregui JM, Croci DO, Correale J, Hernandez JD, Zwirner NW, Poirier F, Riley EM, Baum LG, et al. 2007. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol. 8:825-834.
51. Wada Y, Azadi P, Costello CF, Dell A, Dwek RA, Geyer H, Geyer R, Kakehi K, Karlsson NG, Kato K, et al. 2007. Comparison of the methods for profiling glycoprotein glycans - HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology. 17:411-422.
52. Wassell J. 2000. Haptoglobin: Function and polymorphism. Clin Lab. 46:547-552.
53. Yamashita K, Koide N, Endo T, Iwaki Y, Kobata A. 1989. Altered glycosylation of serum transferrin of patients with hepatocellular carcimona. J Biol Chem. 264:2415-2423.
54. Yu LG, Andrews N, Zhao Q, McKean D, Williams JF, Connor LJ, Gerasimenko OV, Hilkens J, Hirabayashi J, Kasai K, et al. 2007. Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increasedes cancer cell endothelial adhesion. J Biol Chem. 282:773-781.
55. Zhou Q and Cummings RD. 1993. L-14 lectin recognition of laminin and its promotion of in vitro cell adhesion. Arch Biochem Biophys. 300:6-17.